|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 317.60 SEK | -4.34% |
|
-1.91% | +2.19% |
| 08/05 | US FDA Extends Review Period for BioArctic's Co-developed Alzheimer's Therapy | MT |
| 08/05 | Futures point to negative opening for Stockholm Stock Exchange (update) | FW |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 481.21x | 15.13x | -5.1x | 23.03x | 40.36x | 469.98x | 0.63% | 305.51Cr | ||
| 29.29x | 3.52x | 1.33x | 5.18x | 16.05x | 22.56x | 1.12% | 4.34TCr | ||
| 47.3x | 6.95x | 0.29x | 4.76x | 30.21x | 35.72x | -.--% | 3.47TCr | ||
| -17.93x | 13.02x | -0.54x | 275.37x | -16.05x | -16x | -.--% | 3.01TCr | ||
| 21.76x | 4.12x | 4.56x | 2.53x | 10.94x | 16.72x | -.--% | 2.98TCr | ||
| 31.84x | 2.36x | 0.94x | 8.18x | 20.96x | 24.8x | 0.4% | 2.85TCr | ||
| -21.32x | -3785.5x | -0.43x | 13.76x | -21.38x | -20.08x | -.--% | 1.25TCr | ||
| 20.79x | 2.16x | 0.74x | 1.84x | 8.08x | 12.79x | 1.29% | 1.23TCr | ||
| 24.89x | 12.46x | 2.16x | 3.95x | 17.99x | 18.86x | -.--% | 1.21TCr | ||
| -29.59x | 39x | 1.13x | 3023.46x | -33.13x | -29.61x | -.--% | 983.29Cr | ||
| 19.55x | 1.01x | -0.59x | 1.52x | 7.82x | 8.62x | -.--% | 950.6Cr | ||
| -23.41x | 8.22x | -5.1x | 1396.27x | -19.68x | -18.25x | -.--% | 919.13Cr | ||
| 27.74x | 2.62x | -0.09x | 2.67x | 10.27x | 12.65x | -.--% | 855.56Cr | ||
| -24.25x | 20.31x | -0.53x | 6.12x | 150.25x | -423.17x | -.--% | 895.31Cr | ||
| 40.75x | 3.51x | 0.26x | 6.2x | 17.58x | 19.32x | 0.66% | 757.17Cr | ||
| 33.37x | 3.82x | 1.55x | 6.7x | 22.08x | 28.44x | 1.26% | 774.38Cr | ||
| 24.38x | 2.92x | 1.3x | 3.15x | 13.38x | 20.89x | 0.9% | 678.23Cr | ||
| Average | 40.38x | -214.38x | 0.11x | 281.45x | 16.22x | 10.84x | 0.37% | 1.62TCr | |
| Weighted average by Cap. | 22.28x | -165.38x | 0.75x | 189.67x | 13.66x | 3.50x | 0.36% |
- Stock Market
- Equities
- BIOA B Stock
- Sector BioArctic AB
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















